The Global Dermal Fillers Market is expected grow at a fast pace owing to an increasing trend of using anti-ageing treatments, and demand for various devices for dermatology procedures in the market. Rising awareness about skin care and extensive demand for diagnostic and treatment services for skin diseases also influence the growth of the market. Global dermal fillers market is expected to grow at the CAGR of ~12.5% during the forecast period and is estimated to reach USD 10,008.4 million by 2023.
Dermal fillers, also known as facial injectable. These are used to plump up the skin, fill out deep lines and smooth wrinkles. Dermal fillers are gaining popularity all across the globe due to increasing trend of using anti-ageing treatments, and demand to look younger. Growing demand for facial aesthetics globally and increasing acceptance of tissue fillers are driving the growth for the market. Rapid growth of facial surgeries are key driver for the market. Technological advancement and new therapies are also major driving forces of the market.
Increasing number of cosmetic surgeries as well as lifestyle changes further accelerate the market growth. There is an increases in the number of facial injectable surgeries performed on women, as their demand is increasing from last few years, thus boosting the development of the market. Around 91% of facial injectable surgeries are performed on women across the globe. Additionally, availability of well qualified and highly skilled healthcare professional such as dermatologist and surgeons increase the demand for dermal fillers and other dermatology devices and appliances in the market.
Technological advancement further determines the development of dermal fillers market as the key players are now engaged in product differentiation strategy, which is important to sustain the company`s growth and strength its geographical presence.
Dermal Fillers Market – Key Players
ALLERGAN (Republic of Ireland), Dr. Korman Laboratories (Israel), GALDERMA (Switzerland), Integra Lifesciences (US), Merz Pharma (Germany), Sinclair Pharma (UK), and Teoxane laboratories (Switzerland). The major players focus on the development of products useful for particular segment such as nutritional products for adults, children and geriatric population. The major players focus on the development of products useful for particular segment such as nutritional products for adults, children and geriatric population.
Get Sample Report @ https://www.marketresearchfuture.com/sample_request/3893 .
Dermal Fillers Market – Key Developments
Strategic approaches adopted help the major players in the market to sustain their growth and develop their business in various geographical areas across the globe. Agreements and collaborations, mergers and acquisitions, and new product launches are various strategies followed by the key players. This help the companies to reach untapped markets in developing nations of the worlds, thus reducing the supply demand gap.
ALLERGAN:
Allergan has a wind range of products which provides efficient treatment for the central nervous system, eye care, medical aesthetics and dermatology, gastroenterology, women’s health, urology and anti-infective therapeutic categories
June 2017: Allergan announces launch of artificial tear refresh optive mega-3.
June, 2017: Allergan announced the acquisition of Keller Medical, adding Keller Funnel to co’s leading plastic surgery portfolio.
March 2017: Allergan and Editas Medicine enter into strategic research and development alliance. This alliance is to discover and develop Crispr Genome editing medicines for eye diseases.
Galderma:
Galderma is a global leader in dermatology and has strategic partnerships with brands like Soolantra, Tri-Luma, Loceryl, BenzacEpiduo, Oracea, Differin, Mirvaso, Cetaphil, Excipial, Daylong, Restylane, Emervel and many other brands. The company focus on the production of innovative solutions in the field of dermatology for the treatment of various skin diseases such as acne, rosacea, psoriasis, steroid-responsive dermatoses, onychomycosis, pigmentary disorders, skin cancer and other various fields in skin care.
January 2017: Galderma launched two new dermal fillers. In December, Galderma received FDA approval for a pair of next-generation hyaluronic acid (HA) dermal fillers: Restylane Refyne and Restylane Defyne.
January 2017: Galderma announces approval of Azzalure in Europe for treatment of lateral canthal lines in adults. Azzalure, a product in-licensed from Ipsen, received positive opinion from the French regulatory authority, ANSM, for treatment of lateral canthal lines (crow’s feet), either alone or in combination with treatment of glabellar lines.
July 2016: Chugai and Galderma Announce Global License Agreement for Nemolizumab (CIM331), Novel Biologic for Skin Diseases. The primary aim of this agreement is to improve atopic dermatitis by breaking the itch-scratch cycle which has great expectation for nemolizumab.
January 2016: Maruho and Galderma to Join Forces in a Strategic Alliance in Japan. One of the major reasons of this strategic alliance is that galderma will permit maruho to additionally promote their products in japan in the field of dermatology.
Integra Life Sciences:
February 2017: Integra Lifesciences plans to acquire Codman neurosurgery business from Johnson & Johnson.
February 2016: Integra Lifesciences Holdings Corp announces Service Alliance Agreement with PREZIO Health. By this Integra life science will have an authorized service provider for surgical devices and instruments.
May 2015: Integra Lifesciences completes acquisition of TEI Biosciences and TEI Medical. This acquisition Integra will expand their biomedical product profile with collagen based products strengthening the product portfolio of Integra Life Science.
Dermal Fillers Market – Segments
Global Dermal Fillers market has been segmented on the basis of type which comprise botulinum toxin, hyaluronic acid, polymers & particles, and collagen.
On the basis of application, it is segmented into facial line correction treatment, face-lift, and lip treatments, and others.
Get Discount on Report @ https://www.marketresearchfuture.com/check-discount/3893 .
Major Table of Content
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
Continued….
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: salesteam@marketresearchfuture.com
